Business · 20/10/1997Updated: 10/17/2026 · 1 min read
FDA Amends Notice of Cardiovascular and Renal Drugs Advisory Committee Meeting
Summary
The FDA is updating the agenda for the Cardiovascular and Renal Drugs Advisory Committee meeting, removing a previously scheduled item and adding a closed session, with the changes to take effect on October 23, 1997.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →